Company Lookup
عربي
Download Demo
 

Market News

This Month News

This Month News

send to a friend by email

JPH posts net income of $1.92 million in 9M 2016

2016-10-31

According to the financial statements of Jerusalem Pharmaceuticals JPH for the first nine months of 2016, Net profit after tax of the period reached 1,916,996 USD Compared with Net profit after tax 2,896,369 USD for 2015, a net decrease in profit of 33.81%.Total assets of the company reached 55,119,192 USD compared with total assets of 51,192,232 USD at the end of year 2015, a net increase of 7.67%.Total liabilities of the company reached 15,296,318 USD compared with total liabilities of 14,983,341 USD at the end of year 2015, a net increase of 2.08%. Net ownership equity of the company reached 39,822,874 USD (Including Non-Controlling Interests of 539,219 USD) compared with total owner equity of 36,208,891 USD (Including Non-Controlling Interests of 647,664 USD) at the end of year 2015, a net increase of 9.98%.Noting that paid-in capital increased from 17,060,000 USD in year 2015 to 18,000,000 USD of this year, a net increase of 5.51%.


 

2021-04-08
QUDS approves distributing 3.50% stocks dividends and 4.50% cash dividends for the year 2020

2021-04-08
TRUST approves distributing 10% cash dividends for the year 2020

2021-04-08
Relative Calmness in the PEX and a momentum in holding the general assembly meetings

2021-04-08
NCI proposes distributing 10% cash dividends for the year 2020

2021-04-08
PEC approves distributing 10% cash dividends for the year 2020

2021-04-04
NIC approves distributing 15% stocks dividends and 22.5% cash dividends for the year 2020

2021-04-01
APIC proposes distributing 9.1476% stocks dividends and 7.50% cash dividends for the year 2020

2021-04-01
Al-Quds Index declines significantly following the dividends’ entitlement of the PEX’s two largest companies

2021-04-01
BOP approves distributing 1% stocks dividends and 4% cash dividends for the year 2020

 

 

 
Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013